Administration of MELPIDA to Determine the Safety and Efficacy for Patients With Spastic Paraplegia Type 50
Administration of MELPIDA to Determine the Safety and Efficacy for Patients With Spastic Paraplegia Type 50
Active, not recruiting · NCT06069687 · Registry updated 2025-05-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Administration of MELPIDA to Determine the Safety and Efficacy for Patients With Spastic Paraplegia Type 50 | Spastic Paraplegia Type 50 | Active, not recruiting | Phase 1 | 2025-05-14 | NCT06069687 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| The Hospital for Sick Children | 162 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The Hospital For Sick Children | Toronto | Canada | 94 |